Literature DB >> 12187075

Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer.

Fabio Puglisi1, Alessandro Marco Minisini, Giuseppe Aprile, Fabio Barbone, Palmina Cataldi, Daria Artico, Giuseppe Damante, Carlo Alberto Beltrami, Carla Di Loreto.   

Abstract

OBJECTIVE: To evaluate the prognostic value of the balance between apoptosis and proliferation in non-small-cell lung cancer (NSCLC).
METHODS: Paraffin-embedded sections from a consecutive series of radically resected NSCLCs were scored for apoptosis (in situ DNA nick end labeling assay) and proliferation (immunohistochemistry for MIB-1). A total of 1,000 cells were counted per case, to obtain apoptotic (AI) and MIB-1 indices. Other potential prognostic indicators (pT, pN, pStage and histology) and p53 status were also evaluated.
RESULTS: Univariate analysis showed that adenocarcinomatous histotype (p = 0.03), nodal involvement (p = 0.04), higher pStage (p = 0.001) and the combination of low AI and high MIB-1 expression (p = 0.03) were associated with poorer outcome. The significant prognostic value of the combination 'low AI/high MIB-1' was also confirmed in a multivariate analysis after adjustment for other covariates.
CONCLUSION: These results underline the importance of considering apoptosis and proliferation together to identify a subgroup of NSCLC associated with poor survival. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187075     DOI: 10.1159/000065724

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.

Authors:  D Dworakowska; E Jassem; J Jassem; A Karmoliński; R Dworakowski; T Wirth; M Gruchała; A Rynkiewicz; J Skokowski; S Yla-Herttuala; K Jaśkiewicz; E Czestochowska
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.

Authors:  Yuka Yamamoto; Yoshihiro Nishiyama; Naruhide Kimura; Shinya Ishikawa; Masaya Okuda; Shuji Bandoh; Nobuhiro Kanaji; Masato Asakura; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

3.  Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.

Authors:  Song Wen; Wei Zhou; Chun-Ming Li; Juan Hu; Xiao-Ming Hu; Ping Chen; Guo-Liang Shao; Wu-Hua Guo
Journal:  BMC Cancer       Date:  2015-07-15       Impact factor: 4.430

Review 4.  Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review.

Authors:  Charalampos Gkogkou; Konstantina Frangia; Muhammad W Saif; Rodoula Trigidou; Konstantinos Syrigos
Journal:  Springerplus       Date:  2014-03-01

5.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; C Mascaux; T Berghmans; P Lothaire; A-P Meert; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.